Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.

Literature DB >> 15560944

Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.

M Friede¹, M T Aguado.

Abstract

Mesh：

Substances：

Year: 2005 PMID： 15560944 DOI： 10.1016/j.addr.2004.10.001

Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN： 0169-409X Impact factor: 15.470

Keyword Cloud
Cited

× No keyword cloud information.

16 in total

1. Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.

Authors: Fang Wu; Sherry A Wuensch; Mitra Azadniv; Mohammad R Ebrahimkhani; I Nicholas Crispe
Journal: Mol Pharm Date: 2009 Sep-Oct Impact factor: 4.939

Review 2. Design opportunities for actively targeted nanoparticle vaccines.

Authors: Tarek M Fahmy; Stacey L Demento; Michael J Caplan; Ira Mellman; W Mark Saltzman
Journal: Nanomedicine (Lond) Date: 2008-06 Impact factor: 5.307

3. Classification and characterization of therapeutic antibody aggregates.

Authors: Marisa K Joubert; Quanzhou Luo; Yasser Nashed-Samuel; Jette Wypych; Linda O Narhi
Journal: J Biol Chem Date: 2011-03-25 Impact factor: 5.157

4. Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.

Authors: Douglas S Watson; Virginia M Platt; Limin Cao; Vincent J Venditto; Francis C Szoka
Journal: Clin Vaccine Immunol Date: 2010-12-15

Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems.

1. Galactosylated LDL nanoparticles: a novel targeting delivery system to deliver antigen to macrophages and enhance antigen specific T cell responses.

Review 2. Design opportunities for actively targeted nanoparticle vaccines.

3. Classification and characterization of therapeutic antibody aggregates.

4. Antibody response to polyhistidine-tagged peptide and protein antigens attached to liposomes via lipid-linked nitrilotriacetic acid in mice.

5. Self-encapsulating Poly(lactic-co-glycolic acid) (PLGA) Microspheres for Intranasal Vaccine Delivery.

6. The delivery site of a monovalent influenza vaccine within the respiratory tract impacts on the immune response.

Review 7. Nanoparticles for transcutaneous vaccination.

8. Development of thermostable lyophilized inactivated polio vaccine.

9. Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy.

10. A polymer/oil based nanovaccine as a single-dose immunization approach.